-+ 0.00%
-+ 0.00%
-+ 0.00%

CVRx Reports Preliminary Q1 Revenue Range $14.7M - $14.8M, Up From $12.3M YoY

Benzinga·04/13/2026 12:01:24
Listen to the news

CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced certain preliminary unaudited first quarter 2026 financial and operating results.

Total revenue for the first quarter of 2026 is expected to be in the range of $14.7 million to $14.8 million compared to revenue for the first quarter of 2025 of $12.3 million, representing growth of approximately 20%.